We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+28.15%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$448M
AUM Growth
+$56.1M
Cap. Flow
+$34.8M
Cap. Flow %
7.76%
Top 10 Hldgs %
58.47%
Holding
175
New
33
Increased
39
Reduced
41
Closed
56

Top Buys

Rank Stock Value
1
CIVI
Civitas Resources
CIVI
+$3.77M
2
CNC icon
Centene
CNC
+$3.66M
3
DIN icon
Dine Brands
DIN
+$3.44M
4
LMT icon
Lockheed Martin
LMT
+$3.21M
5
FE icon
FirstEnergy
FE
+$2.65M

Sector Composition

Rank Sector Weight
1 Industrials 7.42%
2 Financials 6.92%
3 Consumer Discretionary 6.46%
4 Materials 5.99%
5 Healthcare 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OEF icon
1
PUT
iShares S&P 100 ETF
OEF
$19.8B
$153M 34.03%
626,200
+90,900
+17% +$16M
XNTK icon
2
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2B
$33.3M 7.42%
+245,300
New +$36.3M
GDX icon
3
CALL
VanEck Gold Miners ETF
GDX
$22.7B
$18.7M 4.18%
+416,300
New +$14.2M
MTUM icon
4
PUT
iShares MSCI USA Momentum Factor ETF
MTUM
$24.4B
$13.8M 3.09%
+86,000
New +$14.2M
ARKG icon
5
PUT
ARK Genomic Revolution ETF
ARKG
$1.54B
$11.2M 2.5%
+126,300
New +$12.5M
HRB icon
6
H&R Block
HRB
$5.7B
$7.64M 1.7%
350,575
+34,677
+11% +$655K
TZOO icon
7
Travelzoo
TZOO
$77.8M
$6.53M 1.46%
389,442
+4,961
+1% +$64.9K
CIVI
8
DELISTED
Civitas Resources
CIVI
$6.24M 1.39%
174,693
+133,700
+326% +$3.77M
KGC icon
9
Kinross Gold
KGC
$28.1B
$6.13M 1.37%
919,010
+273,521
+42% +$1.9M
MG icon
10
Mistras Group
MG
$490M
$5.99M 1.34%
525,343
-28,692
-5% -$254K
LRN icon
11
Stride
LRN
$4.08B
$5.6M 1.25%
186,071
-32,516
-15% -$844K
BHC icon
12
Bausch Health
BHC
$1.69B
$5.29M 1.18%
166,636
+31,941
+24% +$937K
PRU icon
13
Prudential Financial
PRU
$43B
$5.22M 1.17%
57,353
+5,405
+10% +$463K
HRB icon
14
CALL
H&R Block
HRB
$5.7B
$4.91M 1.09%
225,000
-478,500
-68% -$9.04M
TAP icon
15
Molson Coors Class B
TAP
$7.97B
$4.43M 0.99%
86,556
+46,373
+115% +$2.25M
FBP icon
16
First Bancorp
FBP
$4.47B
$4.29M 0.96%
380,987
+78,305
+26% +$823K
TYNS
17
PUT
DELISTED
Direxion Daily 7-10 Year Treasury Bear 1X Shares
TYNS
$4.13M 0.92%
+53,700
New +$4.13M
DIN icon
18
Dine Brands
DIN
$458M
$3.98M 0.89%
+44,212
New +$3.44M
LMT icon
19
Lockheed Martin
LMT
$134B
$3.88M 0.87%
10,501
+9,345
+808% +$3.21M
RGA icon
20
Reinsurance Group of America
RGA
$15.9B
$3.79M 0.84%
30,053
+7,515
+33% +$893K
CNC icon
21
Centene
CNC
$31.6B
$3.78M 0.84%
+59,072
New +$3.66M
WKC icon
22
World Kinect Corp
WKC
$2.06B
$3.69M 0.82%
104,919
+2,967
+3% +$101K
CAH icon
23
Cardinal Health
CAH
$54.5B
$3.57M 0.8%
58,840
+37,720
+179% +$2.08M
DHIL
24
DELISTED
Diamond Hill
DHIL
$3.46M 0.77%
22,181
+6,195
+39% +$953K
KOP icon
25
Koppers
KOP
$965M
$3.44M 0.77%
99,091
+12,953
+15% +$454K

Similar funds

Invenomic Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Invenomic Capital Management held 175 positions worth $448M, up 14% from $392M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Invenomic Capital Management deployed $34.8M of net new capital in Q1 2021, opening 33 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 59,072 shares worth $3.78M.

By sector, the portfolio is most concentrated in Industrials at 7.4% of assets, up from 6.8% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Discovery, Inc. Series C Common Stock, an estimated $3.37M trimmed.

  • Invenomic Capital Management's largest Q1 2021 buy was Centene: 59,072 shares worth $3.78M.
  • Invenomic Capital Management added most to Civitas Resources in Q1 2021, an estimated $3.77M increase.
  • Invenomic Capital Management's biggest Q1 2021 reduction was Discovery, Inc. Series C Common Stock, cutting an estimated $3.37M.
  • Invenomic Capital Management fully exited Heidrick & Struggles in Q1 2021, selling an estimated $4.62M.
  • Invenomic Capital Management's ten largest holdings make up 58% of its $448M portfolio in Q1 2021.
  • Invenomic Capital Management opened 33 new positions and closed 56 in Q1 2021.
  • Invenomic Capital Management's portfolio value rose 14% quarter-over-quarter to $448M.

Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.